Research

As a partner of research institutions, health technology companies, policy makers, and investors, my colleagues and I at Wing Tech Inc., a health economics core lab and consultancy, provide critical insight into the value proposition of new medical technologies and treatment strategies throughout the product lifecycle. Our work is frequently developed in close collaboration trial investigators and takes a global scope. See Publications for more detail about recent published studies.

At Stanford, recent work as part of the Biodesign Policy Program has focused on data-driven research to help current and future policymakers better understand how health policies impact innovation.